PDX1 May Link Metabolic Dysfunction to Prostate Cancer Progression
Prostate cancer is the most commonly diagnosed cancer among men and remains a leading cause of cancer-related death worldwide. While age, fa...
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Oncotarget
Traditional scholarly journal with open free-access. Topics on Oncology, Aging, Pathology, Immunology, Microbiology, Autophagy, Cell Death, and Chromosome
Oncotarget Podcast Guide
Listen to Oncotarget, a Science & Medicine podcast by Oncotarget Podcast. Stream 510 episodes in English, follow new audio stories, and play episodes online on Radio and Podcast.
Show Topic
Browse this show under Science & Medicine podcasts.
Episodes
20 episodes are loaded now from a catalog of 510. More episodes can be opened from this page.
Discover More
Explore Science & Medicine podcasts, India podcasts and English podcasts.
Episodes
20 of 510 episodes
HPV Vaccine Shows Safety but Uncertain Benefit in Preventing Head & Neck Cancer Recurrence
BUFFALO, NY – June 15, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on June 5, 2026, titled “A randomized double-b...
Experimental Compounds Trigger Cancer Cell Death in KRAS-Driven Pancreatic Cancer
BUFFALO, NY – June 8, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on June 3, 2026, titled “The anticancer effects...
Cancer Care Often Overlooked in Humanitarian Crises
Cancer is increasingly recognized as a major global health challenge, yet for people living through war, displacement, and humanitarian cris...
Protein in Tumor Microenvironment Found to Promote Colorectal Cancer Growth and Immune Evasion
BUFFALO, NY – June 2, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on May 20, 2026, titled “Microenvironmental CTH...
Immune Checkpoint Inhibitors May Improve Outcomes in High-Risk Solid Tumors
Cancer immunotherapy has transformed the treatment landscape for many advanced cancers over the past decade. Drugs targeting the PD-1 and PD...
Rare Laryngeal Leiomyosarcoma Successfully Treated with Surgery and Adjuvant Chemotherapy
BUFFALO, NY – May 13, 2026 – A new #casereport was #published in Volume 17 of Oncotarget on May 4, 2026, titled “Laryngeal leiomyosarcoma: A...
Agentic AI Systems May Transform Nutritional Care in Oncology
BUFFALO, NY – May 11, 2026 – A new #editorial was #published in Volume 17 of Oncotarget on May 4, 2026, titled “Artificial intelligence in n...
Rare Dual-Mutation GIST Responds to Targeted Therapy, Challenging Established Tumor Biology
BUFFALO, NY – May 6, 2026 – A new #casereport was #published in Volume 17 of Oncotarget on May 4, 2026, titled “Small bowel GIST harboring c...
Mapping the Hidden Structure of Glioma Research: What Are We Missing?
Glioma research has evolved rapidly over the past decade, driven by breakthroughs in molecular biology, imaging technologies, and computatio...
Targeted Therapies Drive Long-Term Decline in Multiple Myeloma Mortality in the U.S.
BUFFALO, NY – April 29, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on April 28, 2026, titled “Targeted therapeut...
SCD1 Inhibition Strategy Shows Potent Synergy with Regorafenib and Metformin in Tumor Cell Killing
Cancer has long been understood through a variety of biological frameworks, including genetic mutations, dysregulated signaling pathways, an...
Epigenetic Dysregulation of PDX1 Drives Prostate Cancer Progression
BUFFALO, NY – April 15, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Epigenetic dysregu...
Cancer Care in Conflict Zones Remains Critically Neglected
BUFFALO, NY – April 13, 2026 – A new #review was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Cancer without borders: Po...
Oncotarget Editorial Highlights Advances in Scientific Integrity and Publishing Transparency
BUFFALO, NY – April 10, 2026 – A new #editorial perspective was #published in Volume 17 of Oncotarget on April 8, 2026, titled “Oncotarget:...
CREB5: A Master Regulator of Stem Cell-Like Programs in Prostate Cancer Progression
Androgen receptor (AR) signaling has long been the central driver of prostate cancer progression and the primary target of therapies for adv...
Adjuvant PD-1/PD-L1 Inhibitors Show Efficacy but Highlight Safety Considerations in Solid Cancers
BUFFALO, NY – April 7, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Efficacy and safety...
Bibliometric Mapping Reveals the Evolution of Glioma Classification Research
BUFFALO, NY – April 6, 2026 – A new #review was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Bibliometric mapping of gli...
The SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Combine to Kill Uveal Melanoma Cells
BUFFALO, NY – March 31, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 27, 2026, titled “The SCD1 inhibitor...
Predicting Colorectal Cancer Survival: How Machine Learning Combines Clinical and Biological Clues
Colorectal cancer (CRC) ranks among the most common and lethal cancers worldwide, accounting for approximately 10% of all cancer diagnoses....